Covidien adds new tech to patient monitoring business
This article was originally published in Clinica
Executive Summary
Covidien is set to enhance its patient monitoring technology with advanced signal processing techniques acquired from CardioDigital. The acquired technology assets will be used by Covidien's respiratory and monitoring solutions business unit and integrated into the Nellocor pulse oximetry platform. Terms of the transaction were not disclosed. In a separate announcement, Covidien reported that its third-quarter fiscal 2008 sales went up 14% to $2.6bn, driving by double-digit growth in it medical devices, imaging solutions and pharmaceutical products business segments. Net income improved to $269m, compared to a loss of $1.1bn recorded in the same quarter in fiscal 2008.